Annual Total Liabilities
$220.18 M
-$6.06 M-2.68%
31 December 2023
Summary:
IGM Biosciences annual total liabilities is currently $220.18 million, with the most recent change of -$6.06 million (-2.68%) on 31 December 2023. During the last 3 years, it has risen by +$193.36 million (+721.04%). IGMS annual total liabilities is now -2.68% below its all-time high of $226.24 million, reached on 31 December 2022.IGMS Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$225.56 M
+$11.42 M+5.33%
30 September 2024
Summary:
IGM Biosciences quarterly total liabilities is currently $225.56 million, with the most recent change of +$11.42 million (+5.33%) on 30 September 2024. Over the past year, it has increased by +$5.07 million (+2.30%). IGMS quarterly total liabilities is now -0.30% below its all-time high of $226.24 million, reached on 31 December 2022.IGMS Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IGMS Total Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -2.7% | +2.3% |
3 y3 years | +721.0% | +383.5% |
5 y5 years | +215.4% | +1380.6% |
IGMS Total Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -2.7% | +721.0% | -0.3% | +383.5% |
5 y | 5 years | -2.7% | +942.5% | -0.3% | +1380.6% |
alltime | all time | -2.7% | +942.5% | -0.3% | +3266.1% |
IGM Biosciences Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $225.56 M(+5.3%) |
June 2024 | - | $214.14 M(-0.3%) |
Mar 2024 | - | $214.88 M(-2.4%) |
Dec 2023 | $220.18 M(-2.7%) | $220.18 M(-0.1%) |
Sept 2023 | - | $220.49 M(-0.7%) |
June 2023 | - | $222.05 M(-0.6%) |
Mar 2023 | - | $223.31 M(-1.3%) |
Dec 2022 | $226.24 M(+325.1%) | $226.24 M(+6.3%) |
Sept 2022 | - | $212.76 M(+2.9%) |
June 2022 | - | $206.79 M(+288.5%) |
Mar 2022 | - | $53.22 M(+0.0%) |
Dec 2021 | $53.22 M | $53.22 M(+14.1%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2021 | - | $46.65 M(+65.4%) |
June 2021 | - | $28.21 M(+13.4%) |
Mar 2021 | - | $24.86 M(-7.3%) |
Dec 2020 | $26.82 M(+27.0%) | $26.82 M(+13.9%) |
Sept 2020 | - | $23.54 M(+6.5%) |
June 2020 | - | $22.10 M(+15.5%) |
Mar 2020 | - | $19.14 M(-9.4%) |
Dec 2019 | $21.12 M(-69.7%) | $21.12 M(+38.6%) |
Sept 2019 | - | $15.23 M(+127.3%) |
June 2019 | - | $6.70 M(-90.4%) |
Dec 2018 | $69.81 M(+66.6%) | $69.81 M |
Dec 2017 | $41.89 M | - |
FAQ
- What is IGM Biosciences annual total liabilities?
- What is the all time high annual total liabilities for IGM Biosciences?
- What is IGM Biosciences annual total liabilities year-on-year change?
- What is IGM Biosciences quarterly total liabilities?
- What is the all time high quarterly total liabilities for IGM Biosciences?
- What is IGM Biosciences quarterly total liabilities year-on-year change?
What is IGM Biosciences annual total liabilities?
The current annual total liabilities of IGMS is $220.18 M
What is the all time high annual total liabilities for IGM Biosciences?
IGM Biosciences all-time high annual total liabilities is $226.24 M
What is IGM Biosciences annual total liabilities year-on-year change?
Over the past year, IGMS annual total liabilities has changed by -$6.06 M (-2.68%)
What is IGM Biosciences quarterly total liabilities?
The current quarterly total liabilities of IGMS is $225.56 M
What is the all time high quarterly total liabilities for IGM Biosciences?
IGM Biosciences all-time high quarterly total liabilities is $226.24 M
What is IGM Biosciences quarterly total liabilities year-on-year change?
Over the past year, IGMS quarterly total liabilities has changed by +$5.07 M (+2.30%)